C12N 9/6437
Coagulation factor viia
Official title: {Coagulation factor VIIa (3.4.21.21)}
C12N9/6437 (Coagulation factor viia) appears on 245 US grants and 445 published applications in this corpus.
Search patents in C12N- Granted patents
- 245
- Published applications
- 445
- Assignees
- 133
- Inventors
- 456
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 3 |
| 2002 | 2 | 4 |
| 2003 | 1 | 14 |
| 2004 | 5 | 13 |
| 2005 | 4 | 12 |
| 2006 | 4 | 34 |
| 2007 | 4 | 14 |
| 2008 | 13 | 20 |
| 2009 | 6 | 26 |
| 2010 | 14 | 21 |
| 2011 | 7 | 20 |
| 2012 | 5 | 17 |
| 2013 | 5 | 20 |
| 2014 | 17 | 47 |
| 2015 | 21 | 24 |
| 2016 | 19 | 30 |
| 2017 | 14 | 19 |
| 2018 | 11 | 20 |
| 2019 | 13 | 20 |
| 2020 | 15 | 17 |
| 2021 | 15 | 19 |
| 2022 | 7 | 11 |
| 2023 | 7 | 9 |
| 2024 | 2 | 2 |
| 2025 | 7 | 7 |
| 2026 | 4 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inter-application workflow performance analytics18 Aug 2026US 12,711,443 B2Box, Inc.
- Gla domains as therapeutic agents14 Jul 2026US 12,678,481 B2Gladiator Biosciences, Inc.
- Tissue factor-targeting CAR-NK and CAR-T cell therapy19 May 2026US 12,630,605 B2Ohio State Innovation Foundation
- Gla domains as targeting agents20 Jan 2026US 12,527,836 B2Gladiator Biosciences, Inc.
- Methods of producing long acting CTP-modified growth hormone polypeptides4 Nov 2025US 12,459,982 B2Opko Biologistics Ltd.
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Novel methods of treating neutorpenia using g-csf protein complex1 Jan 2026US 2026/0000733 A1Hanmi Pharm. Co., Ltd.
- Methods of treating neutorpenia using g-csf protein complex4 Dec 2025US 2025/0367257 A1Hanmi Pharm. Co., Ltd.
- Method of producing biologically active vitamin k dependent proteins by recombinant methods21 Aug 2025US 2025/0263769 A1Aptevo Biotherapeutics LLC
- Methods of treatment using g-csf protein complex19 Jun 2025US 2025/0197466 A1
Most cited
By later US patents
- Immunoglobulin chimeric monomer-dimer hybrids215US 7,404,956 B2Syntonix Pharmaceuticals, Inc. · 2008
- Expression of factor VII activity in mammalian cells201US 4,784,950 AZymoGenetics, Inc. · 1988
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Immunoglobulin chimeric monomer-dimer hybrids165US 7,348,004 B2Syntonix Pharmaceuticals, Inc. · 2008